ClinicalTrials.gg
Not yet recruitingNCT07931820Updated Nov 12, 2026

Translating Indoor Air Quality Data Into Action

An interventional study of LCM-O (monitor only) and LCM-R (monitor + generic reminders) in Environmental Exposure, sponsored by Boston University. Not yet recruiting. Open to female participants aged 21 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Boston University · Not applicable, Interventional, and Health services research

Updated Nov 12, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
21 Years to 45 Years
Sex
Female
01

Study summary

Poor indoor air quality affects the health of millions of Americans. People spend most of their time indoors, yet indoor air can be more polluted than outdoor air. Many everyday activities, such as cooking, using fireplaces, cleaning, and using air fresheners, affect indoor air quality, but most people don't know how their choices affect the air they breathe.

This study will test whether giving people information about their indoor air quality motivates them to make healthier choices. We will work with 120 households, providing them with air quality monitors and sending different types of information about their indoor air quality. Through randomized assignment, some will receive general tips, while others will get personalized messages based on their home's air quality patterns.

By understanding how to best help people create healthier indoor environments, respiratory health can e protected across diverse communities. This research could lead to practical, affordable ways for families to breathe cleaner air at home.

02

Conditions studied

  • Environmental Exposure

Keywords

  • Indoor air quality (IAQ)
  • Indoor air quality monitor
  • Generic reminders
  • Personalized insight reminders
  • PRESTO
03

In context

Lead sponsor

Boston University is the lead sponsor of 271 studies on the registry; 37 are open to participants now.

Of its 31 completed or terminated interventional studies of FDA-regulated products, 24 (77%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Is an active female participant in PRESTO (aged 21-45 years and trying to conceive at PRESTO enrollment, per PRESTO eligibility) who has completed the PRESTO baseline questionnaire and has not withdrawn from PRESTO.
  2. Lives in the United States and has a residence where a monitor can be safely placed for approximately four months after the baseline period.
  3. Has home Wi-Fi internet that the monitor can connect to.
  4. Has a smartphone or tablet that can run the monitor's companion app.
  5. Does not plan to move out of her current home within the next 6 months.
  6. Is willing to complete the study activities: monthly online questionnaires for 6 months, four 2-day activity logs, keeping the monitor plugged in at home for about 4 months, undergo random assignment, receiving study emails, text messages, and other communication, and returning the monitor at the end.
  7. Be able to provide in English.

Exclusion criteria

Exclusion Criteria:

  1. Currently has an indoor air quality monitor in the home that displays levels of particles, VOCs, or CO2 (smoke alarms, carbon monoxide alarms, and radon detectors do not count). Rationale: households that already see IAQ data cannot provide a true "no-monitor" baseline period.
  2. Is an employee, student, or trainee of any member of the study team.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Active comparator
    LCM-O (monitor only)

    Participants randomized to this arm will only receive a LCM-O monitor.

    Other: LCM-O (monitor only)

  • Active comparator
    LCM-R (monitor + generic reminders)

    Participants randomized to this arm will receive a LCM-O monitor and generic reminders.

    Other: LCM-R (monitor + generic reminders)

  • Experimental
    LCM-I (monitor + personalized insights)

    Participants randomized to this arm will receive a LCM-O monitor and personalized insights.

    Other: LCM-I (monitor + personalized insights)

Interventions

  • OtherLCM-O (monitor only)

    Indoor air quality monitor with real-time display and companion app; standard setup and safety guide; routine study operational messages (e.g., questionnaire reminders), which contain no IAQ content.

  • OtherLCM-R (monitor + generic reminders)

    Everything in Arm 1, plus a brief generic IAQ tip and reminder to review the monitor every two weeks, drawn from a fixed library based on EPA guidance and the literature (8 messages over 4 months, starting 2 weeks after activation).

  • OtherLCM-I (monitor + personalized insights)

    Everything in Arm 1, plus a personalized message every two weeks that describes patterns in the household's own monitor data from the previous 14 days and suggests one or two specific actions, with links to further information (8 messages, starting 2 weeks after activation).

06

What researchers measure

Primary outcomes

  1. Indoor Air Quality (IAQ) Behavior Score

    The IAQ Behavior Score measures how human actions, habits, or responses contribute to or mitigate indoor pollution. Data will be collected from a IAQ questionnaire. The score will range from 1-100 and higher scores are more favorable.

    Time frame: Baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Feb 2027; primary completion for Jan 2029, 23 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 6, 2026
First posted
Nov 12, 2026
StartEst.
Feb 2027
Primary completionEst.
Jan 2029
CompletionEst.
Jan 2029
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07931820
Lead sponsor
Boston University
Collaborators
American Lung Association
Responsible party
Sponsor
First posted
Nov 12, 2026
Start date
Feb 2027 (estimated)
Primary completion
Jan 2029 (estimated)
Completion
Jan 2029 (estimated)
Last update
Nov 12, 2026

Study contacts

Kipruto Kirwa, PhD, MPH
Contact
kirwa@bu.edu
617-358-1911
Eliza Pentz, MS
Contact
eppentz@bu.edu
617-358-3728
Kipruto Kirrwa, PhD, MPH
principal investigator · Boston University School of Public Health, Environmental Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion